Emergent BioSolutions is investing in Swiss biotech Rocketvax, inking a deal designed to fuel the preclinical company’s R&D.
ABB, a Swiss tech company, is investing $120 million to expand operations in Mississippi and Tennessee. The expansion will ...
The project is funded by the Canton of Zurich and Swiss national railway Schweizerische Bundesbahnen (SBB) and managed by the Swiss Transit Lab (STL), with WeRide providing products and ...